Actinium Pharmaceuticals, Inc. (ATNM)
1.22
+0.03
(+2.52%)
USD |
NYAM |
Sep 18, 16:00
1.21
-0.01
(-0.82%)
After-Hours: 20:00
Actinium Pharmaceuticals Price to Book Value : 1.266 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.266 |
| September 17, 2026 | 1.235 |
| September 16, 2026 | 1.287 |
| September 15, 2026 | 1.297 |
| September 14, 2026 | 1.328 |
| September 11, 2026 | 1.453 |
| September 10, 2026 | 1.359 |
| September 09, 2026 | 1.276 |
| September 08, 2026 | 1.276 |
| September 04, 2026 | 1.069 |
| September 03, 2026 | 1.090 |
| September 02, 2026 | 1.038 |
| September 01, 2026 | 1.033 |
| August 31, 2026 | 1.058 |
| August 28, 2026 | 1.048 |
| August 27, 2026 | 1.038 |
| August 26, 2026 | 1.048 |
| August 25, 2026 | 1.121 |
| August 24, 2026 | 1.090 |
| August 21, 2026 | 1.141 |
| August 20, 2026 | 1.162 |
| August 19, 2026 | 1.172 |
| August 18, 2026 | 1.121 |
| August 17, 2026 | 1.090 |
| August 14, 2026 | 1.079 |
| Date | Value |
|---|---|
| August 13, 2026 | 1.000 |
| August 12, 2026 | 0.852 |
| August 11, 2026 | 0.8229 |
| August 10, 2026 | 0.7992 |
| August 07, 2026 | 0.8274 |
| August 06, 2026 | 0.8166 |
| August 05, 2026 | 0.7769 |
| August 04, 2026 | 0.8405 |
| August 03, 2026 | 0.842 |
| July 31, 2026 | 0.8684 |
| July 30, 2026 | 0.8685 |
| July 29, 2026 | 0.8684 |
| July 28, 2026 | 0.8991 |
| July 27, 2026 | 0.8865 |
| July 24, 2026 | 0.8923 |
| July 23, 2026 | 0.9245 |
| July 22, 2026 | 0.9338 |
| July 21, 2026 | 0.9338 |
| July 20, 2026 | 0.9162 |
| July 17, 2026 | 0.9566 |
| July 16, 2026 | 0.9235 |
| July 15, 2026 | 0.9545 |
| July 14, 2026 | 0.9288 |
| July 13, 2026 | 0.939 |
| July 10, 2026 | 0.965 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.595 |
| Alnylam Pharmaceuticals, Inc. | 23.66 |
| Anika Therapeutics, Inc. | 2.029 |
| Savara, Inc. | 7.678 |
| Vericel Corp. | 5.534 |
Price to Book Value Related Metrics
| PE Ratio | 3.420 |
| PS Ratio | 1.087 |
| Price | 1.22 |
| Earnings Yield | 29.24% |
| Market Cap | 38.36M |
| Operating PE Ratio | 3.991 |
| Normalized PE Ratio | 3.420 |